Relationship between combination of baseline viral load and CD4 cell count, and Week 48 or 96 responses to rilpivirine (RPV) or efavirenz (EFV) in treatment-naïve HIV-1-infected adults: pooled analysis from the Phase III ECHO and THRIVE trials

Authors
Category Primary study
Conference19th Conference on Retroviruses and Opportunistic Infections (CROI); 2012 Mar 5-8; Seattle, WA, United States.
Year 2012
This article has no abstract
Epistemonikos ID: 197683047d5d037b8520a21a2801d193911213aa
First added on: Apr 18, 2022